U
Upstream Bio, Inc. (UPB)
NMS – Real Time Price. Currency in USD
6.93
-0.15 (-2.19%)
Market open: Aug 12, 2026, 12:21 PM EDT
7.09
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 4:20 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
6.93
-0.15 (-2.19%)
Market open: Aug 12, 2026, 12:21 PM EDT
7.09
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 4:20 PM EDT
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
| Name | Position |
|---|---|
| Dr. Adam Houghton M.B.A., Ph.D. | Chief Business Officer |
| Dr. E. Rand Sutherland M.D., M.P.H. | CEO & Director |
| Meggan Buckwell | Director of Corporate Communications & Investor Relations |
| Mr. Aaron Deykin M.D. | Chief Medical Officer and Head of Research & Development |
| Mr. Michael Paul Gray CPA, MBA | CFO & COO |
| Ms. Allison C. Ambrose J.D. | Senior VP, General Counsel & Secretary |
| Ms. Fang Xie Ph.D. | VP & Head of Biometrics |
| Ms. Lisa Fiering | Senior Vice President of People & Culture |
| Ms. Mersedeh Miraliakbari Pharm.D. | Senior Vice President of Regulatory Affairs & Quality |
| Ms. Stacy Price M.S., P.M.P. | Chief Technology Officer |
| Date | Type | Document |
|---|---|---|
| 2026-08-11 | 8-K | upb-20260811.htm |
| 2026-06-10 | 8-K | upb-20260609.htm |
| 2026-05-13 | 8-K | upb-20260513.htm |
| 2026-05-13 | 10-Q | upb-20260331.htm |
| 2026-04-16 | DEFA14A | defa14a_2026_proxy.htm |
| 2026-04-16 | DEF 14A | upb-20260416.htm |
| 2026-03-26 | 8-K | upb-20260326.htm |
| 2026-02-11 | 8-K | d44802d8k.htm |
| 2025-11-05 | S-3ASR | d44481ds3asr.htm |
| 2025-11-05 | 8-K | upb-20251105.htm |